Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation
ID: 356169Type: Forecasted
Overview

Buyer

Centers for Disease Control - NCEZID (HHS-CDC-NCEZID)

Award Range

$75K - $100K

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356169
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation." This initiative aims to enhance educational resources for families affected by CJD and to inform public health service providers and at-risk groups about human prion diseases, ultimately striving to reduce the incidence of preventable forms of these diseases. With an estimated total program funding of $500,000, the CDC plans to award a cooperative agreement with a funding range between $75,000 and $100,000, and applications must be submitted electronically by March 18, 2025, for consideration. For further inquiries, interested applicants can contact Tracey Ponder at 404-639-0953 or via email at TPonder@cdc.gov.

    Point(s) of Contact
    Tracey Ponder
    (404) 639-0953
    TPonder@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at increasing awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States. The initiative seeks to enhance AGS surveillance, patient care, and public understanding through strategies that include public health tracking, targeted education for at-risk populations, and dissemination of knowledge among stakeholders. With an estimated total program funding of $2,250,000, the CDC anticipates awarding three grants, with individual awards ranging from $25,000 to $1,000,000. Interested applicants can reach out to Jeff Borchert at JBorchert@cdc.gov or by phone at 970-221-6494, with applications due by January 22, 2025, and awards expected to be announced by July 1, 2025.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Public Health Strategies to Address Alzheimer's Disease and Related Dementias," aimed at enhancing public health initiatives through cooperative agreements. This initiative seeks to support organizations in developing and implementing strategies that align with the National Healthy Brain Initiative Road Map, focusing on areas such as dementia risk reduction, early detection, and caregiver support. The funding opportunity is critical as Alzheimer's disease is a leading cause of death among older adults in the U.S., and the program aims to build evidence-based practices to improve brain health and support caregivers. Interested applicants can apply for one or more of the three components, with funding amounts ranging from $750,000 to $3 million, and must submit their applications by March 7, 2025. For further inquiries, contact Alisha Etheredge at BOLD@cdc.gov or call 770-488-7884.
    Modeling Infectious Diseases in Healthcare (MInD Healthcare) to Improve Pathogen Prevention and Healthcare Delivery
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Modeling Infectious Diseases in Healthcare (MInD Healthcare) to Improve Pathogen Prevention and Healthcare Delivery." This initiative aims to support the development of innovative mathematical models and computational tools to analyze the spread of pathogens in healthcare settings, predict outbreaks, and assess intervention strategies, thereby enhancing public health responses to healthcare-associated infections and antimicrobial resistance. The program is particularly significant for private institutions of higher education, with a total estimated funding of $19.5 million, expected to yield six awards ranging from $550,000 to $650,000 each. Interested applicants should note that proposals must be submitted electronically by April 2, 2025, with the anticipated award date set for July 1, 2025. For further inquiries, contact Nga Vuong at 970-494-6682 or via email at ypg2@cdc.gov.
    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled "Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)." This initiative aims to support investigator-initiated research focused on identifying and evaluating potential risk factors associated with ALS, particularly those related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. The program is significant for advancing understanding of ALS and its risk factors, especially in diverse populations, including racial and ethnic minorities and military veterans. Interested applicants can apply for funding ranging from $0 to $500,000, with an estimated total program funding of $7.5 million available for approximately eight awards. Applications must be submitted electronically by November 4, 2024, and inquiries can be directed to Candis M. Hunter, PhD, MSPH, REHS, at ncipcerpo@cdc.gov.
    Enhancing Public Health Surveillance of Bleeding Disorders
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.
    Epilepsy Incidence Among Children in the United States
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a grant opportunity titled "Epilepsy Incidence Among Children in the United States," aimed at understanding the incidence of epilepsy among U.S. children aged 0 to 17 years. The primary objectives include estimating epilepsy incidence using comprehensive nationwide datasets, identifying risk factors associated with developing epilepsy, and examining disparities in incidence rates across various demographics and social determinants of health. This research is crucial for informing public health policies and resource allocation to improve healthcare services for affected populations. The estimated total program funding is $1.6 million, with a maximum award ceiling of $500,000, and interested applicants must submit their proposals by January 23, 2025. For further inquiries, contact Alison Amoroso at aamoroso@cdc.gov or call 470-395-2521.
    Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to address significant gaps in lupus awareness and care by supporting national organizations in reducing the time to diagnosis, improving care coordination, and enhancing self-management among lupus patients. The program is particularly focused on increasing healthcare provider education and promoting effective self-management tools for individuals affected by lupus, a systemic autoimmune disease that disproportionately impacts women, especially those from minority communities. The estimated total program funding is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are due by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.
    Medical Monitoring Project
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for the Medical Monitoring Project (MMP), aimed at enhancing the understanding of the experiences and needs of adults diagnosed with HIV in the United States. This initiative involves a comprehensive surveillance system that collects clinical and behavioral data through interviews and medical chart abstractions, providing valuable insights for prevention planning, policy-making, and resource advocacy. With an estimated total program funding of $70.5 million and the expectation of awarding 23 cooperative agreements, eligible applicants include state health departments and select local health departments, with applications due by January 31, 2025. For further inquiries, interested parties can contact Jason Craw at (404) 639-6395 or via email at emf4@cdc.gov.
    Advancing Public Health Actions to Prevent and Control Chronic Disease in the U.S. Territories and Freely Associated States
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Advancing Public Health Actions to Prevent and Control Chronic Disease in the U.S. Territories and Freely Associated States." This cooperative agreement aims to support integrated, evidence-based strategies to prevent and manage chronic diseases in U.S. territories and freely associated states, addressing significant health challenges such as high disease burden and limited healthcare infrastructure. The program will focus on reducing modifiable risk factors associated with chronic diseases, with an estimated total funding of $17,450,000 available for approximately eight awards, ranging from $230,000 to a ceiling of $1,400,000. Interested applicants must submit their proposals by January 15, 2025, and can contact Monique Young at 770-488-3434 or via email at islandprogdp25-0024@cdc.gov for further information.